[Beta-lactamase inhibitors].
Nishiya
H
H
Second Department of Internal Medicine, University of Teikyo.
Kunii
O
O
D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology; D001419:Bacteria / Q000201:enzymology; D001426:Bacterial Proteins / Q000378:metabolism; D001665:Binding Sites; D001667:Binding, Competitive; D002969:Clavulanic Acids / Q000378:metabolism / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D006868:Hydrolysis; D007769:Lactams; D013407:Sulbactam / Q000378:metabolism / Q000494:pharmacology; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000145:classification / Q000378:metabolism; D047090:beta-Lactams
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D002969:Clavulanic Acids; D007769:Lactams; D065093:beta-Lactamase Inhibitors; D047090:beta-Lactams; C061593:C6-(N1-methyl-1,2,3-trazolylmethylene)penem; D001618:beta-Lactamases; D013407:Sulbactam